Niethammer, A. G., Mikus, G., Knebel, P., Hohmann, N., Leowardi-Bauer, C., Beckhove, P., . . . Schmitz-Winnenthal, F. H. (2012). Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and locally advanced pancreatic cancer. BMC cancer, 12, . https://doi.org/10.1186/1471-2407-12-361
Chicago-Zitierstil (17. Ausg.)Niethammer, Andreas Gerhard, et al. "Double-blind, Placebo-controlled First in Human Study to Investigate an Oral Vaccine Aimed to Elicit an Immune Reaction Against the VEGF-Receptor 2 in Patients with Stage IV and Locally Advanced Pancreatic Cancer." BMC Cancer 12 (2012). https://doi.org/10.1186/1471-2407-12-361.
MLA-Zitierstil (9. Ausg.)Niethammer, Andreas Gerhard, et al. "Double-blind, Placebo-controlled First in Human Study to Investigate an Oral Vaccine Aimed to Elicit an Immune Reaction Against the VEGF-Receptor 2 in Patients with Stage IV and Locally Advanced Pancreatic Cancer." BMC Cancer, vol. 12, 2012, https://doi.org/10.1186/1471-2407-12-361.